OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.04 billion. The enterprise value is $1.37 billion.
| Market Cap | 1.04B |
| Enterprise Value | 1.37B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 696.99 million shares outstanding. The number of shares has decreased by -5.94% in one year.
| Shares Outstanding | 696.99M |
| Shares Change (YoY) | -5.94% |
| Shares Change (QoQ) | -5.99% |
| Owned by Insiders (%) | 52.41% |
| Owned by Institutions (%) | 23.58% |
| Float | 330.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 64.52 |
| PS Ratio | 1.30 |
| Forward PS | 1.35 |
| PB Ratio | 0.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | -2.87 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.92 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.08 |
Financial Efficiency
Return on equity (ROE) is -18.00% and return on invested capital (ROIC) is -11.91%.
| Return on Equity (ROE) | -18.00% |
| Return on Assets (ROA) | -12.30% |
| Return on Capital (ROIC) | -11.91% |
| Revenue Per Employee | $203,461 |
| Profits Per Employee | -$64,232 |
| Employee Count | 3,930 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 7.99 |
Taxes
In the past 12 months, OPKO Health has paid $1.85 million in taxes.
| Income Tax | 1.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.70% in the last 52 weeks. The beta is 1.65, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -30.70% |
| 50-Day Moving Average | 1.32 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 68.36 |
| Average Volume (20 Days) | 3,801,368 |
Short Selling Information
The latest short interest is 84.31 million, so 12.10% of the outstanding shares have been sold short.
| Short Interest | 84.31M |
| Short Previous Month | 87.48M |
| Short % of Shares Out | 12.10% |
| Short % of Float | 25.47% |
| Short Ratio (days to cover) | 21.17 |
Income Statement
In the last 12 months, OPKO Health had revenue of $799.60 million and -$252.43 million in losses. Loss per share was -$0.35.
| Revenue | 799.60M |
| Gross Profit | 260.93M |
| Operating Income | -197.90M |
| Pretax Income | -250.58M |
| Net Income | -252.43M |
| EBITDA | -128.11M |
| EBIT | -232.78M |
| Loss Per Share | -$0.35 |
Balance Sheet
The company has $75.64 million in cash and $408.77 million in debt, giving a net cash position of -$333.13 million or -$0.48 per share.
| Cash & Cash Equivalents | 75.64M |
| Total Debt | 408.77M |
| Net Cash | -333.13M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 1.80 |
| Working Capital | 186.97M |
Cash Flow
In the last 12 months, operating cash flow was -$41.12 million and capital expenditures -$15.24 million, giving a free cash flow of -$56.36 million.
| Operating Cash Flow | -41.12M |
| Capital Expenditures | -15.24M |
| Free Cash Flow | -56.36M |
| FCF Per Share | -$0.08 |
Margins
Gross margin is 32.63%, with operating and profit margins of -24.75% and -31.57%.
| Gross Margin | 32.63% |
| Operating Margin | -24.75% |
| Pretax Margin | -31.34% |
| Profit Margin | -31.57% |
| EBITDA Margin | -16.02% |
| EBIT Margin | -29.11% |
| FCF Margin | -7.05% |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.94% |
| Shareholder Yield | 5.94% |
| Earnings Yield | -24.31% |
| FCF Yield | -5.43% |
Analyst Forecast
The average price target for OPKO Health is $2.50, which is 67.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 67.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.49 |
| Piotroski F-Score | 3 |